The FTSE 100 was down very slightly in early trading, following falls in the US and Asia. The markets continue to wait and see what’s going to happen to Liz Truss’ UK government.
Tesla reported mixed fortunes in its third quarter results with revenue missing Wall Street expectations by around 2%.
Dunelm saw a decline in first-quarter sales but kept its full-year guidance unchanged despite the “challenging macroeconomic environment.”
Marlboro cigarette-maker Philip Morris raised its buyout offer by 9% for Swedish Match, weeks before a deadline to get enough shareholder support for the US$16bn deal.
C4X Discovery said it is teaming up with Shanghai-listed drug developer HitGen to identify ‘hits’ against a small molecule inflammatory target.
Europe-based MGC Pharma said it is ‘extremely well placed’ to deliver products across the EU and globally, reporting that it has hit several operational and quality milestones.
And Technology Minerals said it hit high-grade lithium during its first work programme on a new licence in County Wexford, Republic of Ireland.
